CDK5 has also been found to phosphorylate dynamin-related protein 1 (DRP1), thereby stimulating its activity in brain tumor-initiating cells; DRP1 activation correlates with poor prognosis in glioblastoma (Xie et al., 2015). The gene discussed is DNM1L; the disease is brain neoplasm.